Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Message from the Chair

Kerry-Anne Rye, PhD, FAHAWelcome to the Arteriosclerosis, Thrombosis and Vascular Biology Council! Our council engages scientists and clinicians working to improve the prevention, diagnosis and treatment of atherosclerotic, vascular, and thrombotic diseases in the US and worldwide. Council membership includes investigators with interests that range from discovery science to clinical research. Read Dr. Rye's full message

Kerry-Anne Rye, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Diversity

ATVB Council Diversity Committee
Mary Sorci-Thomas, PhD, interviews Mahdi Garelnabi, PhD, MSc, the chair, and Gissette Reyes-Soffer, MD, the vice chair of the Diversity Committee for the Council on ATVB about some of their recent initiatives.

Science NewsView All Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with und...
Venous Thromboembolism Research Priorities
07/08/2020 | Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the U.S. and worldwide.

Funding Opportunities

AHA research programs are available to basic, clinical and population scientists.

ATVB

ATVB Journal Cover

The latest and greatest research in the fields of arteriosclerosis, thrombosis and vascular biology.

Women's Leadership Committee

The latest and greatest research in the fields of arteriosclerosis, thrombosis and vascular biology.